| Metric | შპს ნიუ ფარმა | შპს თბილისი მედიკ | შპს დენკ ფარმა კავკასია |
|---|---|---|---|
| Growth | |||
| Revenue | ₾14.6m₾21.9m | ₾14.8m₾14.3m | ₾22.1m₾20.5m |
| Revenue growth | -33.2% | 3.5% | 7.7% |
| Profitability | |||
| EBITDA | -₾27k₾3.5m | ₾827k₾1.8m | ₾2.4m₾833k |
| EBITDA margin | -0.2%15.8% | 5.6%12.3% | 10.7%4.1% |
| Net profit | -₾1.2m₾2.1m | -₾2.2m₾1.9m | |
| ₾1.4m₾589k |
| Net margin | -8.4%9.7% | -14.8%13.2% | 6.4%2.9% |
| Balance sheet | |||
| Total assets | ₾9.7m₾10.9m | ₾18.7m₾19.7m | ₾13.2m₾11.6m |
| Total equity | ₾3.4m₾5.9m | ₾14.2m₾16.3m | ₾4.6m₾4.7m |
| ROE | -35.4%36.1% | -15.5%11.6% | 30.4%12.5% |